Warner SL - Search Results

1

A small-molecule inhibitor of PIM kinases as a potential treatment for urothelial carcinomas.

Foulks JM, Carpenter KJ, Luo B, Xu Y, Senina A, Nix R, Chan A, Clifford A, Wilkes M, Vollmer D, Brenning B, Merx S, Lai S, McCullar MV, Ho KK, Albertson DJ, Call LT, Bearss JJ, Tripp S, Liu T, Stephens BJ, Mollard A, Warner SL, Bearss DJ, Kanner SB. Foulks JM, et al. Among authors: warner sl. Neoplasia. 2014 May;16(5):403-12. doi: 10.1016/j.neo.2014.05.004. Epub 2014 Jun 18. Neoplasia. 2014. PMID: 24953177 Free PMC article.

2

Targeting Aurora-2 kinase in cancer.

Warner SL, Bearss DJ, Han H, Von Hoff DD. Warner SL, et al. Mol Cancer Ther. 2003 Jun;2(6):589-95. Mol Cancer Ther. 2003. PMID: 12813139 Review.

3

Identification of a lead small-molecule inhibitor of the Aurora kinases using a structure-assisted, fragment-based approach.

Warner SL, Bashyam S, Vankayalapati H, Bearss DJ, Han H, Mahadevan D, Von Hoff DD, Hurley LH. Warner SL, et al. Mol Cancer Ther. 2006 Jul;5(7):1764-73. doi: 10.1158/1535-7163.MCT-05-0524. Mol Cancer Ther. 2006. PMID: 16891462

4

Tubulin-associated proteins: Aurora and Polo-like kinases as therapeutic targets in cancer.

Warner SL, Stephens BJ, Von Hoff DD. Warner SL, et al. Curr Oncol Rep. 2008 Mar;10(2):122-9. doi: 10.1007/s11912-008-0020-0. Curr Oncol Rep. 2008. PMID: 18377825 Review.

5

Pdx-1-driven overexpression of aurora a kinase induces mild ductal dysplasia of pancreatic ducts near islets in transgenic mice.

Warner SL, Muñoz RM, Bearss DJ, Grippo P, Han H, Von Hoff DD. Warner SL, et al. Pancreas. 2008 Oct;37(3):e39-44. doi: 10.1097/MPA.0b013e318176b9ae. Pancreas. 2008. PMID: 18815537 Free PMC article.

6

Validation of TPX2 as a potential therapeutic target in pancreatic cancer cells.

Warner SL, Stephens BJ, Nwokenkwo S, Hostetter G, Sugeng A, Hidalgo M, Trent JM, Han H, Von Hoff DD. Warner SL, et al. Clin Cancer Res. 2009 Nov 1;15(21):6519-28. doi: 10.1158/1078-0432.CCR-09-0077. Epub 2009 Oct 27. Clin Cancer Res. 2009. PMID: 19861455 Free PMC article.

7

S110, a 5-Aza-2'-deoxycytidine-containing dinucleotide, is an effective DNA methylation inhibitor in vivo and can reduce tumor growth.

Chuang JC, Warner SL, Vollmer D, Vankayalapati H, Redkar S, Bearss DJ, Qiu X, Yoo CB, Jones PA. Chuang JC, et al. Among authors: warner sl. Mol Cancer Ther. 2010 May;9(5):1443-50. doi: 10.1158/1535-7163.MCT-09-1048. Epub 2010 May 4. Mol Cancer Ther. 2010. PMID: 20442312 Free PMC article.

8

In vitro and in vivo characterization of SGI-1252, a small molecule inhibitor of JAK2.

Ahmed KB, Warner SL, Chen A, Gourley ES, Liu X, Vankayalapati H, Nussenzveig R, Prchal JT, Bearss DJ, Parker CJ. Ahmed KB, et al. Among authors: warner sl. Exp Hematol. 2011 Jan;39(1):14-25. doi: 10.1016/j.exphem.2010.09.013. Epub 2010 Oct 8. Exp Hematol. 2011. PMID: 20934482

9

Competitive enhancement of HGF-induced epithelial scattering by accessory growth factors.

Chung JY, Davis JA, Price BD, Staley DM, Wagner MV, Warner SL, Bearss DJ, Hansen MD. Chung JY, et al. Among authors: warner sl. Exp Cell Res. 2011 Feb 1;317(3):307-18. doi: 10.1016/j.yexcr.2010.11.002. Epub 2010 Nov 11. Exp Cell Res. 2011. PMID: 21075102

10

Targeting Axl and Mer kinases in cancer.

Verma A, Warner SL, Vankayalapati H, Bearss DJ, Sharma S. Verma A, et al. Among authors: warner sl. Mol Cancer Ther. 2011 Oct;10(10):1763-73. doi: 10.1158/1535-7163.MCT-11-0116. Epub 2011 Sep 20. Mol Cancer Ther. 2011. PMID: 21933973 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

95 results

Search Page